Tag: pharmaceuticals
-
Therapy Shown to Boost Immune System Against Cancer
18 April 2016. An experimental treatment was shown in lab mice to enhance immune system cells that can help immunotherapy drugs to reduce solid tumor growth. Researchers from Memorial Sloan Kettering Cancer Center in New York and Infinity Pharmaceuticals in Cambridge, Massachusetts presented their findings yesterday (17 April) at the annual meeting of American Association…
-
Challenge Seeks Diabetic Kidney Disease Treatments
15 April 2016. A challenge on InnoCentive is asking for new techniques to deliver drugs to specialized kidney cells in patients with kidney damage caused by diabetes. The competition has a total purse of $20,000 and a deadline of 13 May 2016 for submissions. The sponsor of the challenge, pharmaceutical company Boehringer Ingelheim, is also…
-
Implanted Device Delivers Pancreatic Cancer Drugs
15 April 2016. An engineering and medical research team developed an implanted device that in lab mice delivers chemotherapy directly to cancerous tumors in the pancreas. The device, designed in a biomedical engineering lab at Massachusetts Institute of Technology and Harvard University, is described in an article appearing 31 March 2016 in the journal Biomaterials…
-
Emergency Snakebite Treatment in Development
14 April 2016. A new treatment for rattlesnake bites, designed as emergency first-aid until reaching a clinic, is being developed at University of Arizona medical school in Tucson. The therapy, still in preclinical stages, is the work of anesthesiology professor Vance Nielsen and toxicologist Leslie Boyer, founder and director of Arizona’s Viper Institute — short…
-
Technique Extends Bioactive Device Coating Lifetime
14 April 2016. A new process is shown to regenerate therapeutic coatings on implanted medical devices in lab tests and with animals, possibly extending the devices’ lifetimes in patients. The techniques, developed in the lab of Harvard University biomedical engineering professor Elliot Chaikof, are described in the 13 April 2016 issue of the journal Nature…
-
Charity Starts Industry-Backed Cancer Research Effort
13 April 2016. The charitable group Stand Up to Cancer unveiled today a new program to spur research on cancer treatments begun by pharmaceutical companies. The program known as Catalyst will harness funds and products from participating companies that will be bid out to the research community at large for further research and development. Charter…
-
Start-Up Licensing Biologic Delivery Nanoparticles
8 April 2016. A start-up enterprise is licensing research from a university pharmacy lab that harnesses nanoscale particles to boost the performance of biologic therapies. Financial details of the agreement between Zoetic Pharmaceuticals in Amherst, New York and University at Buffalo were not disclosed. Biologic therapies are synthetic proteins derived from living systems, such as…
-
Cancer Centers, Analytics, Pharma Plan Precision Medicine
7 April 2016. A cancer care center network, with pharmaceutical and informatics companies, plan to apply precision medicine techniques to increase the pool of patients for clinical trials of new cancer therapies. The coalition includes cancer centers in the Orien network — short for Oncology Research Information Exchange Network — with bioinformatics company M2Gen, and…
-
Trial Shows Pain Drug Effective as Heroin Treatment
7 April 2016. A clinical trial in Canada shows a drug already in use for chronic pain can serve as a substitute maintenance treatment for people addicted to heroin. The findings of the trial, conducted by University of British Columbia in Vancouver and other institutions in Canada, appear 6 April in the journal JAMA Psychiatry.…
-
Stem Cell Biotech Licensing Blood Vessel Repair Technology
6 April 2016. Cellular Dynamics International, a developer of regenerative treatments from stem cells, is licensing university research that repairs blood vessels in people with peripheral artery disease. Financial aspects of the deal between Indiana University and Cellular Dynamics, a subsidiary of FujiFilm in Madison, Wisconsin, were not disclosed. Cellular Dynamics designs and generates induced…